Introduction
Apoptosis is the process whereby individual cells of multicellular organisms undergo systematic self-destruction in response to a wide variety of stimuli. Apoptosis plays an important role in maintaining normal tissue homeostasis. Disruption of this process is believed to result in aberrant cell survival, which may contribute to oncogenesis and tumor progression (Williams, 1991; Liebermann et al., 1995) . It is not surprising that cancer cells would gain a selective growth advantage by blocking apoptosis. In fact, disruption of apoptosis has been linked to many aggressive features of malignant tumor cells, such as tumorigenicity (Wu, 1996) , metastatic potential (Glinsky and Glinsky, 1996; Xie et al., 1995) and drug resistance (Desoize, 1994; Smets, 1994) . Thus, disruption of apoptosis is a major factor in the multistep process of tumorigenesis.
Since apoptosis plays such an important role in tumor biology, the factors driving (or antagonizing) this process need to be understood for de®ning the mechanism and exploitation of its therapeutical potential. It is conceivable that certain genetic or epigenetic events occurred in tumor cells which ultimately favor their survival and subsequent tumor progression. On the other hand, it is also possible that the aggression of tumor cells, or the corresponding malignant phenotype, can be suppressed or reversed by the introduction of a therapeutic gene that promotes apoptosis, a feature that may be useful for cancer therapy. The adenovirus 5 (Ad5) E1A gene may provide a useful tool to study this function. The protein products of the E1A gene can induce apoptosis in many dierent cell types, which was mostly characterized by adenovirus infection and analysed in vitro (White and Stillman, 1987; Lowe and Ruley, 1993; Mymryk et al., 1994; Rao et al., 1992; Debbas and White, 1993; Boulakia et al., 1996) . As infection by adenovirus results in transient gene expression, the metabolic and genetic consequences of the gene expression after cell division can not be examined. Expression of the E1A gene in stably transfected human carcinoma cells has been shown to increase sensitivity to the cytotoxicity of several anticancer agents (Sanchez-Prieto et al., 1995 . However, these reagents normally do not exist in natural host and it is not clear whether the E1A gene alone can mediate apoptosis in vivo under physiological condition. Expression of E1A by adenovirus infection has been shown to induce apoptosis in context with the treatment of serum deprivation or TNF in normal rat kidney (NRK) cells and NIH 3T3 mouse ®broblast cells (Rao et al., 1992; Mymryk et al., 1994; Shisler et al., 1996) . However, it is not clear whether these eects can be induced in natural tumor cells and linked to the in vivo tumor suppression mediated by E1A.
Deprivation of growth factors usually causes apoptosis in growth factor-dependent cells, but not in many other types of cells, especially cancer cells. If this apoptotic response can be induced in tumor cells, it may have great impact on tumor growth, since acquisition of growth autonomy and apoptotic resistance are common features of malignant cells (Shih and Herlyn, 1993) . Because this in vitro activity has not been characterized in vivo, the relevance of this in vitro activity to its in vivo biological function remains to be examined. Indeed, growth of solid tumors in vivo is a complex process. There are numerous factors in vivo which may either favor or oppose the apoptotic process. The outcome may therefore be dierent from what is observed in vitro. These factors may include cell-cell contact, cell-extracellular matrix contact (Frisch, 1994) , multicellular architecture (Kerbel, 1994 ± 95) , angiogenesis (Wu, 1996; Glinsky and Glinsky, 1996) , hypoxia (Graeber et al., 1996) , organ environment , local immunity (Donawho et al., 1996) and autocrine or paracrine growth factors (Shih and Herlyn, 1993) . Thus, characterization of corresponding features in vivo would be important for evaluation of the net outcome, which may serve as overall parameters for the eects in particular organ environments. The analysis would help to elucidate the role of the interactions of these factors with tumor cells in vivo and provide a functional link between in vitro models and in vivo events. This information, in turn, may have great impact on designing more ecient strategies for cancer therapy.
Previously, E1A has been shown to mediate tumor suppression on several types of HER-2/neu overexpressed human cancer cells (Yu et al., 1993; Zhang et al., 1995; Chang et al., 1996 Chang et al., , 1997 . This function has been linked to its ability to repress the transcription of oncogene HER-2neu (Yu et al., 1993; . In addition, E1A has also been shown to mediate tumor suppression in a number of types of human cancer cells in which overexpression of oncogene HER-2/neu is not involved, suggesting that multiple pathways might be involved in E1A-mediated tumor suppression (Frisch and Dolter, 1995) . However, the mechanisms remain to be elucidated.
In rodent cells, adenovirus type 5 E1A was shown to function as an immortalization oncogene through cooperation with ras or E1B oncogene (Houwelling et al., 1980; Ruley, 1983) . However, E1A was also found to suppress transformation and malignant phenotypes of HER-2/neu or ras transformed mouse embryonic ®broblast cell line (Pozzatti et al., 1986) . Thus, it raises an interesting question whether E1A could function as a tumor suppressor in natural rodent tumor cells. To address these questions, we chose a murine melanoma cell line, K1735 M2, for biological characterization. Melanoma is a type of cancer in which HER-2/neu has not been found to be involved in its tumorigenesis (Peris et al., 1991) . It thus provides a rodent tumor model for study of the mechanism of E1A-mediated tumor suppression which is independent of suppression of oncogene HER-2/neu. The melanoma cell line K1735M2, derived from UV-exposured skin of C3H mice (Kripke, 1979; Pierceall et al., 1992) , is highly tumorigenic and metastatic in both athymic nude mice and immune competent syngenic C3H mice. The K1735 M2-C3H model has been widely used and well characterized (Chen et al., 1992; Townsend and Allison, 1993; Chen and Ananthaswamy, 1993) . We introduced the Ad5 E1A gene into the murine melanoma cells and characterized their biological properties both in vitro and in vivo. The results of this study showed: (i) Ad5 E1A can mediate tumor suppression in rodent tumor cells; (ii) E1A-mediated tumor suppression associated with E1A-mediated apoptosis both in vitro and in vivo and (iii) the apoptosis induction property of E1A may be used for improvement of its therapeutic ecacy by combining dierent anti-cancer approaches together.
Results

E1A mediated tumor suppression in murine melanoma
To characterize the biological functions of the E1A gene in rodent tumor cells, we established stable E1A transfectants by transfection of murine melanoma K1735 M2 cells with plasmid pAd5 E1A-neo, which encodes the genomic adenovirus type 5 E1A gene. Control transfectants were created using plasmid pSV 2 -neo, which only encodes the neomycin resistance gene. After selection in medium containing G418, dierent subclones of the transfectants were screened for E1A proteins by immunoblot using M58 anti-E1A monoclonal antibody. Two E1A transfectant clones (KA4 and KA9), as well as parental cells (K) and vector alone transfectant (KSP), were used in the subsequent studies ( Figure 1a) .
We ®rst examined the in vitro growth rate of E1A transfectants in comparison with parental and vector alone transfected tumor cells. The growth rate of each cell line was determined by quantitating viable cells using trypan blue exclusion ( Figure 1b ). As shown in Figure 1b , the E1A transfectants, vector alone transfectants and parental cells exhibited similar growth rates. This result was con®rmed by MTT assay (data not shown). Thus, E1A did not aect the growth rate of these tumor cells in vitro.
Next, we analysed the anchorage-independent growth of cells in soft agarose. Anchorage-independent growth in soft agarose is generally considered to be a marker of transformation and to correlate well with tumorigenicity. As shown in Figure 1c , the numbers of formed colonies were markedly decreased in the E1A-expressing clones (KA4 and KA9) compared with parental and vector alone cells. Thus, expression of the E1A gene resulted in suppression of a transformed phenotype.
Finally, we assayed the tumorigenicity of the E1A transfectants in vivo (Figure 1d and e). Parental cells (K) and vector alone transfectant (KSP) formed large size tumors, while E1A transfectants, KA4 and KA9, only formed very small size tumors ( Figure 1d ). To examine whether the E1A gene was still expressing, tumors were isolated and examined by Western blot against E1A (data not shown). The results indicated that the E1A gene was still expressed in those small tumors. Thus, E1A greatly suppressed tumor growth in nude mice, although it does not completely eliminate tumorigenicity in vivo. Taken together, although E1A does not aect the growth rate of rodent tumor cells in vitro, it greatly suppresses tumor growth in vivo.
E1A sensitizes melanoma cells to apoptosis induced by serum depletion
Another property of tumor cells is growth autonomy. In contrast to normal cells, tumor cells are usually less dependent on growth factors present in culture medium. To correlate biological functions with the possible mechanisms involved, we analysed the responses of the cell lines to serum depletion, a stress mimicking growth factor withdrawal in growth factordependent cell lines. As shown in Figure 2 , serum deprivation resulted in a gradual loss of cell viability in the E1A transfectants (KA4 and KA9) but not in parental (K) and control (KSP) cells. Morphologically, many of the E1A-transfected tumor cells (KA9 in Figure 3 ) (KA4 not shown) lost contact with their neighbors, becoming rounded up and shrunken, a process resembling apoptosis.
To con®rm that loss of viability was indeed due to the process of apoptosis, the samples were further analysed by FACS (¯uorescence-activated cell sorting) analysis and DNA fragmentation assay. As shown in Figure 4a , the population of subG1 phase (apoptotic cells) measured by FACS analysis increased in the E1A transfectants (KA9) following serum depletion. There was no measurable increase in the subdiploid population for the control cells (KSP) (K, data not shown). To characterize the pattern of DNA fragmentation, low molecular weight DNA was extracted and analysed for formation of DNA ladders, a hallmark of apoptosis. As shown in Figure 4b , DNA ladders appeared in the E1A transfectants (KA9) (KA4 is similar to KA9, data not shown) after serum depletion, but not in parental cells (KSP) (K is similar to KSP, data not shown). Thus, compared with parental tumor cells, the E1A transfectants became more growth factor dependent and sensitive to apoptosis induction.
E1A-mediated apoptosis identi®ed in vivo: a unique apoptotic pattern
Although apoptosis can be arti®cally induced in the E1A transfected melanoma cells in vitro, it is not clear whether such an event may occur in vivo, since the physiological environment in vivo is completely To examine the eect of E1A on tumor cells in vivo, tumor tissues derived from control and E1A-transfected cells were isolated and analysed by in situ TUNEL (TdT-mediated dUTPbiotin nick and labeling) assay. As shown in Figure 5 , apoptotic cells were indeed identi®ed in E1A-expressing tumor tissues, but not in tumor tissues from control tumor cells (KSP). Interestingly, most of the apoptotic cells were found at the periphery of the tumors. This ®nding has several implications: (i) E1A-mediated apoptosis did occur in vivo, which associated, and probably participated in, the process of tumor suppression; (ii) activation of E1A-mediated apoptotic program might require additional stress signals enriched at the periphery of tumor tissues in vivo since the cells at this region were more aected. Thus, it is likely that both expression of the E1A gene and action of in vivo stress stimuli are required to trigger the apoptotic program.
E1A sensitizes melanoma cells to a variety of stress stimuli and anticancer agents
To link the stress stimuli to those potential apoptotic triggers that may be involved in vivo, we then examined the sensitivity of the E1A transfectants to those potential factors which exist in vivo and possibly serve such a role, such as tumor necrosis factor-alpha (TNF-a).
TNF-a is known as a major mediator of natural killer (NK) cells and activated macrophages which are still involved in the nude mouse model and likely to be enriched around the periphery of tumor tissues (Cook et al., 1989) . As shown in Figure 6a and d, treatment with TNF-a induced apoptosis in E1A transfectants, but not in parental and vector control tumor cells. This result is consistent with the concept that in vivo factors, such as TNF-a, could function as stress signals which trigger the apoptotic response in vivo.
Since stress stimuli can greatly enhance E1A-mediated apoptosis, such property may be utilized to enhance E1A-mediated tumor suppression, a potential strategy to increase the therapeutical ecacy of gene therapy for cancer. We therefore examined the sensitivity of E1A-transfected melanoma cells to two types of these agents, cisplatin (CDDP), and g radiation. Cisplatin and g radiation are therapeutic agents commonly used in the treatment of melanoma (Jansen et al., 1997) . It is known that both of these agents exert their action through the induction of apoptosis (Chu, 1994) . As shown in Figure 6b , c and d, E1A transfectants exhibited a markedly increased sensitivity to apoptosis induced by both g radiation and cisplatin in comparison with parental (K) and control (KSP) cells. Taken together, these results suggest that E1A converted an apoptosis-resistant malignant tumor cell line to a less malignant, apoptosis-sensitive one. It is likely that synergistic antitumor eects could be achieved by combining these anticancer agents with E1A-based targeted gene therapy.
Discussion
E1A has been shown to have tumor suppressor activities in human cancers both in vitro and in vivo, including breast carcinoma, ovarian carcinoma, rhabdomyosarcoma, osteosarcoma, melanoma and nonsmall lung carcinoma (Yu et al., 1993; Zhang et al., 1995; Chang et al., 1996 Chang et al., , 1997 Frisch, 1991; Frisch and Dolter, 1995) . The biological functions of E1A in rodent cells were expected to be dierent from those in human cells (Frisch and Dolter, 1995; Mymryk, 1996) , since the natural host for adenovirus are human epithelial cells. In fact, E1A was initially described as an oncogene in rodent cells due to its role in immortalization and transformation by cooperation with a second oncogene (Houwelling et al., 1980; Ruley, 1983) . It has been suggested that rodent cells are semi-or non-permissive for adenovirus replication, and infection can lead to transformation (Peeper and Zantema, 1993) . However, the underlying mechanism could be complicated by the fact that a particular ) from four cell lines were each seeded in three wells in a 24-well plate. One day later, the growth medium for each well was replaced with media without serum. The numbers of viable cells were counted by method of trypan blue at the indicated times after serum depletion. Results are presented as the percentage of viable cells referenced to the day of serum removal E1A tumor suppression and apoptosis induction J Deng et al feature from in vitro assay may vary depending on the assays, cell types and context of other factors. As E1A mediates multiple biochemical and biological functions, the net outcome of its functions should be based on the sum of all events. The results of this study clearly indicate that E1A is also able to mediate tumor suppression in rodent tumor cells, indicating that it functions as a general tumor suppressor. Figure 4 Analysis of apoptotic cells after serum depletion. (a) FACS analysis. Cells of each cell line (KSP and KA9), which were either in medium with 10% FCS or treated with serum depletion for 2 days (0.1% FCS), were trypsinized, ®xed and stained with PI. The samples were then subjected to¯ow cytometry as described. (b) DNA fragmentation. Cells (5610 5 cells/100 mm dish) were seeded in medium with 10% FCS, and treated with serum depletion 1 day later. Genomic DNA was isolated from both¯oating and adherent cells of each sample at indicated time. Low molecular weight DNA was analysed by 1.6% agarose gel electrophoresis E1A tumor suppression and apoptosis induction J Deng et al Transcriptional repression of HER-2/neu has been shown to be associated with E1A-mediated tumor suppressive function. This mechanism appears to play an important role in suppression of the tumorigenicity of HER-2/neu overexpressing cancer cells, such as breast carcinoma, ovarian carcinoma and non-small lung carcinoma (Yu et al., 1992 (Yu et al., , 1993 Zhang et al., 1995; Chang et al., 1996 Chang et al., , 1997 . A HER-2/neu independent tumor suppressive activity was also found in several human cancer cell lines (Frisch and Dolter, 1995) . The melanoma cells used in this study do not overexpress HER-2/neu (data not shown), and thus provide a model to study the HER-2/neu-independent mechanisms of E1A-mediated tumor suppression in rodent tumor cells.
Expression of the E1A gene in the murine melanoma cells resulted in a dramatically altered morphology and increased susceptibility to apoptosis. Importantly, this activity has been shown to occur in vivo by the in situ TUNEL assay, which provides direct evidence to link the in vitro activity with the in vivo biological function. Interestingly, there were more apoptotic cells concentrated around the periphery of the E1A-expressing tumor tissues. This observation has several implications: (i) E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo; (ii) induction of E1A-mediated apoptosis in vivo may require additional stress stimuli which may exist around the periphery of tumor tissues.
There were far fewer apoptotic cells identi®ed in tumor tissues in vivo than those induced in vitro. There are several possibilities. First, in contrast to the twodimensional growth in monolayers in vitro, tumor cells that resided in the tumor mass were growing in a threedimensional which has multicellular architecture. The cells in the interior of tumor mass were relatively inaccessible to potential stress signals due to steric hindrance. Thus, scattered single cells and the cells on the periphery of the tumor might be more susceptible to apoptosis, because they were more accessible to these signals than those in the interior. Second, it was suggested that the speed of apoptosis and clearance of apoptotic bodies in vivo is rapid (a few hours at most) (Bellamy et al., 1995) . Apoptosis is a dynamic process, and the in situ TUNEL assay could only re¯ect a transient period during the process. Thus, identi®cation of a few apoptotic bodies in a tissue section may represent a considerable degree of cumulative cell loss. Numerically small dierences in`apoptotic index' can therefore be of great biologic impact. For example, anti-CD4 antibody increases the apoptotic index in murine lymph nodes from 0.06 to 1.33%, and this is sucient to halve the total cell count of the lymph node within 48 h (Bellamy et al., 1995) .
Expression of the Ad2/5 E1A gene in cancer cells has been shown to induce the cytolytic susceptibility to TNF-a (Chen et al., 1987; Duerksen-Hughes et al., 1989) , which might contribute suppression of tumorigenicity of some cancer cells (Tsuji et al., 1993) . TNFa is the major eector of both NK cells and activated macrophages (Cook et al., 1989) which still exist in nude mice, determination of the sensitivity of the E1A transfectants to TNF-a may therefore be relevant to the circumstance observed in vivo. The E1A-transfected melanoma cells used in this study were indeed sensitive to TNF-a in vitro (Figure 6a and d) , which is consistent with the observation in vivo. However, further investigation is needed to address whether TNF-a or other factors might be involved in the in vivo apoptosis observed in this study.
The parental K1735 M2 cell line contains active Nras mutation, but no p53 mutation (Pierceall et al., 1992; Anathaswamy, personal communication) . It has been shown that activation of the ras pathway was involved in increased sensitivity to TNF-induced apoptosis in mouse ®broblasts (Trent et al, 1996) . However, E1A-mediated sensitization to apoptosis is unlikely to be ras-dependent, since E1A also mediated apoptosis in other cell types in which ras mutation was not involved (White and Stillman, 1987; Lowe and Ruley, 1993; Mymryk et al., 1994; Rao et al., 1992; Debbas and White, 1993; Teodoro et al., 1995) . In addition, the E1A-transfectants used in this study were also sensitive to other stress stimuli, including doxorubicin (data not shown) which was shown to be ras-independent (Trent et al., 1996) .
Carcinogenesis is recognized as a multistep process which may result from the disregulation of either cell proliferation or cell death. Disruption of apoptosis may be of primary importance in the formation and progression of malignancies (Canman and Kastan, 1995) . It is probable that cancer cells have an enhanced apoptotic threshold while the E1A gene can reduce the threshold for apoptosis induction. Since many of the malignant features were inversely correlated with apoptosis, it is not surprising that tumor cells would also be suppressed by introduction of an apoptosis-inducing gene like E1A. Thus, E1A might suppress the malignant features by converting those apoptosis-resistant tumor cells into apoptosissensitive ones, such as the one indicated in this study. Interestingly, the immortalization oncogene E1A,
In Vitro
In Situ KSP KA9 Figure 5 Analysis of apoptotic cells by TUNEL assay. In vitro TUNEL assay: Cells (5610 4 cells/well) were seeded in 10% FCS medium in a six-well plate. The next day, serum was removed from the culture medium. Three days after serum removal, cells were trypsinized and collected for TUNEL assay. In situ TUNEL assay: Tumor samples were obtained from mice 10 days after injection with E1A transfected tumor cells (KA9) and control tumor cells (KSP). The excised sections of tumor tissues were used for the assay E1A tumor suppression and apoptosis induction J Deng et al which was originally de®ned in rodent cells, can also mediate tumor suppression in natural rodent tumor cells. As the outcome is the sum of all events occurring in that cellular context, E1A actually functioned as a tumor suppressor in rodent tumor cells
Materials and methods
Animals
Speci®c-pathogen-free female BALB/c athymic nude (nu/ nu) mice, and syngenic C3H/HeN (H-2k) mice, 6 ± 8 weeks old, were obtained from Harlan Sprague Dawley, Inc., (Indianapolis, IN, USA). The care and use of the animals was in accordance with institutional guidelines.
Cell Lines
K1735 subclone M2 cell line, kindly provided by Dr JE Price (Department of Cell Biology, MD Anderson Cancer Center, Houston, TX, USA), is a murine melanoma induced in a C3H/HeN (H-2k) mouse by initiation with ultraviolet radiation and promotion with repeated croton oil treatment (Kripke, 1979; Pierceall, et al., 1992) . Tumor cells were grown in Dulbecco's modi®ed Eagle's medium/ F12 medium (GIBCO Laboratories, Grand Island, NY, USA) supplemented with 10% fetal calf serum. The K1735 M2 E1A transfectants (KA4 and KA9) and K1735 M2 vector transfectants (KSP) were grown under the same conditions, with addition of G418 (200 mg/ml) to the medium.
Drug and treatments
Cisplatin (Sigma), doxorubicin (Sigma), and human recombinant TNF (Genentech) were used at concentration indicated. All dilutions were performed in growth medium.
In g-radiation, cells were irradiated with a Cs 137 as source at doses as indicated.
DNA transfection
All DNA transfections were carried out using the calciumphosphate procedure (Graham and van der Eb, 1973) . E1A transfectants were obtained by transfection of K1735 M2 cells with plasmid pE1A-neo which encodes the Ad5 E1A gene. Control vector transfectants were obtained by transfection with pSV 2 -neo which encodes only neomycin resistance gene. The transfectants were selected in medium containing G418 (500 mg/ml), and were maintained in medium containing G418 (200 mg/ml).
Soft agar colony formation assays
The ability of dierent cell lines to grow in soft agarose was determined as previously described (Yu et al., 1993) . Brie¯y, cells (1610 3 cells/well) were plated in a 24-well plate in culture medium containing 0.35% agarose (BRL, Gaithersburg, MD, USA) overlying a 0.7% agarose layer. The cells were incubated at 378C for 3 ± 4 weeks, after which the plates were stained with p-iodonitrotetrazolium violet (1 mg/ml) for 48 h at 378C.
Growth rates
The in vitro growth rates of the cell lines were assessed by measuring increases in cell number or viability using MTT assay (Yu et al., 1993) . For determination of cell number, 1.5610 4 cells (0.5 ml) of the same sample were plated in each of four wells in a 24-well plate. The cells were trypsinized and the cell number per well was determined by trypan blue exclusion. For MTT assay, cells (3610 3 /well) were plated in 96-well culture plates in 0.1 ml of culture medium. The plates were analysed at the indicated time by addition of 20 ml MTT (Sigma Chemical Co., St Louis, MO, USA) stock solution (1.25 mg MTT/ml of phosphatebuered saline PBS) to each well. Cells were incubated at 378C for 2 ± 3 h, and the cells were lysed by adding 100 ml of 12.5% sodium dodecyl sulfate (SDS), 45% dimethylformide (DMF). Conversion of MTT to formazan by metabolically viable cells was monitored using a Dynatech MR 5000¯uorescence microplate reader at a wavelength of 590 nm.
Tumorigenicity assay
Cells in log-phase growth were trypsinized, washed twice with PBS and centrifuged at 1000 g. Viable cells were counted; then 1610 6 cells in 0.2 ml of serum-free medium were injected s.c. into one¯ank of mice. Tumor volume was estimated as the product of three-dimensional caliper measurements.
Immunoblot
Immunoblot analysis were performed as previously described (Yu et al., 1990) . The primary monoclonal antibodies used were M53 against the E1A proteins (Pharmagen, CA, USA), c-neu-Ab-3 against the neuencoded p185 protein (Oncogene Science Inc., Manhasset, NY, USA) and antibody against b-actin for sample loading control. The blots were then incubated with horseradishconjugated rabbit antimouse immunoglobulin (Bio-Rad Laboratories, Richmond, CA, USA) and ECL (enhanced chemiluminescence) Western blotting detection reagents (Amersham, UK).
DNA fragmentation assays
Cells were harvested from the culture medium by low-speed centrifugation and washed once with PBS. Samples were lysed in 100 ml TE9S buer (Tris-HCl, 2 mM EDTA, 10 mM NaCl, and 1% (w/v) SDS, pH 9.0) containing 1 mg of proteinase K/ml by incubation at 508C overnight. Low-molecular-weight DNA was selectively collected by addition of NaCl to 1 M and centrifugation at 55 000 r.p.m. for 30 min. The isolated DNA was extracted once with phenol/chloroform, and then once with chloroform as described (Hirt, 1967; White et al., 1984) . Samples were then treated for 1 ± 3 h at 258C with RNase A (300 mg/ml) and loaded onto 1.6% (w/v) agarose gels containing ethidium bromide (10 mg/ml).
Flow cytometry
Analysis of apoptotic cells by¯ow cytometry was performed as described (Nicoletti et al., 1991) . Brie¯y, trypsinized cells were washed with PBS, then ®xed with 70% ethanol overnight at 48C. Before analysis, cells were washed with PBS, and then added¯uorochrome solution (propidium iodide (PI) 50 mg/ml in 0.1% sodium citrate plus 0.1% Triton X-100 (Sigma).
TUNEL assay
TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay was performed as described (Gavrieli et al., 1992) . Brie¯y, nuclei of tissue sections were stripped from proteins by incubation with 20 mg/ml proteinase K for 15 min at room temperature (RT). Slides were then washed in distilled water four times. Endogenous peroxidase was inactivated by covering the sections with 2% H 2 O 2 for 5 min at RT. The sections were rinsed with distilled water and immersed in TDT buer (30 mM Tris, pH 7.2, 140 mM sodium cacodylate, 1 mM cobalt chloride). TDT (0.3 e.u./ml) and biotinylated dUTP in TDT buer were then added to cover the sections, which were incubated in humid atmosphere at 378C for 60 min. The reaction was terminated by transferring the slides to TB buer (300 mM sodium chloride, 30 mM sodium citrate) for 15 min at RT. The sections were rinsed with distilled water, covered with 2% aqueous solution of bovine serum albumin (BSA) for 10 min at RT, rinsed in distilled water, and immersed in PBS for 5 min. The sections were covered with extra-avidin peroxidase diluted 1 : 10 ± 1 : 30 min at 378C, washed in distilled water, immersed for 5 min in PBS and stained with AEC for about 30 min at 378C.
